| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/10/2005 | WO2005012549A2 Apparatus and methods for evaluating the barrier properties of a membrane |
| 02/10/2005 | WO2005012544A2 Methods for the identification of inhibitors of mannosyltransferase and mannosyltransferase complex subunit as antibiotics |
| 02/10/2005 | WO2005012530A2 Antagonists and agonists of ldcam and methods of use |
| 02/10/2005 | WO2005012509A2 Method for immunotherapy of tumors |
| 02/10/2005 | WO2005012506A2 Extended primary retinal cell culture and stress models, and methods of use |
| 02/10/2005 | WO2005012505A2 Nanoparticle and microparticle based detection of cellular products |
| 02/10/2005 | WO2005012502A2 Methods of identifying optimal variants of peptide epitopes |
| 02/10/2005 | WO2005012497A2 Translocation tagging |
| 02/10/2005 | WO2005012482A2 Assay for identification of bioactive compounds that interact with heat shock protein 90 |
| 02/10/2005 | WO2005012479A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/10/2005 | WO2005012361A2 Antibodies raised against colon carcinomas |
| 02/10/2005 | WO2005012353A1 Crystalline tumor necrosis factor receptor 2 polypeptides |
| 02/10/2005 | WO2005012352A1 SOLUBLE HUMAN INTERLEUKIN 18 RECEPTOR-α, METHOD OF ASSAYING THE SAME, ASSAY KIT AND MEDICINAL COMPOSITION |
| 02/10/2005 | WO2005012350A2 Epha2 t-cell epitope agonists and uses therefor |
| 02/10/2005 | WO2005012343A1 Babesia vaccines |
| 02/10/2005 | WO2005012338A1 Antigenic peptides of sars coronavirus and uses thereof |
| 02/10/2005 | WO2005012330A2 AMYLOID β-PEPTIDE AND METHODS OF USE |
| 02/10/2005 | WO2005012329A2 Kinase and phosphatase assays |
| 02/10/2005 | WO2005012247A1 Compounds and methods for the rapid quantitative analysis of proteins and polypeptides |
| 02/10/2005 | WO2005011866A1 Method and device for chemical or biological analysis by a sensor with a monolithic chamber in the form of a multi-microtubular sheaf and a lateral integration measuring transducer |
| 02/10/2005 | WO2005011748A2 Method and device for deactivating items and for maintaining such items in a deactivated state |
| 02/10/2005 | WO2005011728A2 Use of soluble cd164 in inflammatory and/or autoimmune disorders |
| 02/10/2005 | WO2005011619A2 Lung-expressed polypeptides |
| 02/10/2005 | WO2005011612A2 Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism |
| 02/10/2005 | WO2005011607A2 Treatment of cancers expressing p95 erbb2 |
| 02/10/2005 | WO2005011599A2 Antibodies specific for toxic amyloid beta protein oligomers |
| 02/10/2005 | WO2005011590A2 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 02/10/2005 | WO2005011576A2 Digital chromatography |
| 02/10/2005 | WO2005011489A1 Processing analyte sensor data |
| 02/10/2005 | WO2005011474A2 Multiple high-resolution serum proteomic features for ovarian cancer detection |
| 02/10/2005 | WO2005005966A3 Device for lateral flow tests |
| 02/10/2005 | WO2005003771A9 Two-layer antibody capture system |
| 02/10/2005 | WO2004111081A3 Antigenic peptides of sars coronavirus and uses thereof |
| 02/10/2005 | WO2004108743A3 Support comprising immobilised carbohydrate molecules and its use |
| 02/10/2005 | WO2004107618A3 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof |
| 02/10/2005 | WO2004106929A3 Assay method |
| 02/10/2005 | WO2004106924A3 Testing cell cycle regulation effect of a compound using a hollow fibre cell implant |
| 02/10/2005 | WO2004099564A3 A method and apparatus for a downhole micro-sampler |
| 02/10/2005 | WO2004097421A3 Diagnostics and therapeutics for diseases associated with calcitonin receptor-like receptor (calcrl) |
| 02/10/2005 | WO2004097358A3 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2) |
| 02/10/2005 | WO2004093903A3 Methods and compositions for immunomodulation using cd1 antigens |
| 02/10/2005 | WO2004091372A3 Methods of assessing crohn’s disease patient phenotype by i2, ompc and asca serologic response |
| 02/10/2005 | WO2004071465A3 Methods and kits for use in the diagnosis and treatment of endotoxemia |
| 02/10/2005 | WO2004067551A3 Method for identifying peptides by mass spectrometry |
| 02/10/2005 | WO2004060860A3 Method for inhibiting the replication of herpes viruses |
| 02/10/2005 | WO2004058050A3 Amplified cancer target genes useful in diagnosis and therapeutic screening |
| 02/10/2005 | WO2004047614A3 Methods, biosensors and kits for detecting and identifying fungi |
| 02/10/2005 | WO2004039953A3 Array oligomer synthesis and use. |
| 02/10/2005 | WO2004024068A3 Novel composition and methods for the treatment of immune related diseases |
| 02/10/2005 | WO2004019001A3 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 02/10/2005 | WO2003086175A8 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/10/2005 | WO2003072752A3 Improved substrate chemistry for protein immobilization on a rigid support |
| 02/10/2005 | WO2003072723A3 Intracellular signaling molecules |
| 02/10/2005 | WO2003060065A3 Adapter-directed display system |
| 02/10/2005 | WO2003058194A3 Affinity labeling of enzymes for detection of enzyme activity level in living cells |
| 02/10/2005 | WO2003050295A3 Assays and implements for determining and modulating hsp90 binding activity |
| 02/10/2005 | WO2003030624A3 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 02/10/2005 | WO2003025117A3 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 02/10/2005 | WO2003012676A3 Method for calculating a characteristic property of a molecule by correlation analysis |
| 02/10/2005 | WO2002101072A3 Letm1: modulators of cellular proliferation |
| 02/10/2005 | WO2002072872A3 System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby |
| 02/10/2005 | WO2002064626A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/10/2005 | WO2002020718A3 Osteoclast-associated receptor |
| 02/10/2005 | US20050034185 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 02/10/2005 | US20050034179 Transgenic animal cell which express tumor necrosis factor receptor for use in identifying agents for treatment of diabetes and inflammatory bowel disease |
| 02/10/2005 | US20050033900 System, method, and computer software product for specifying parameters associated with a biological probe array |
| 02/10/2005 | US20050033530 Flow rate determination |
| 02/10/2005 | US20050033525 Method and system for computing and applying a user-defined, global, multi-channel background correction to a feature-based data set obtained from reading a microarray |
| 02/10/2005 | US20050033148 Module for a computer interface |
| 02/10/2005 | US20050033038 Reaction of phosphorothioate derivative with phenolic compound |
| 02/10/2005 | US20050033018 Receptors and membrane-associated proteins |
| 02/10/2005 | US20050033017 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/10/2005 | US20050032834 Administering a chloroquine compound as an anticarcinogenic, antiischemic, anticholesterol, or anxiolytic agent |
| 02/10/2005 | US20050032744 Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds |
| 02/10/2005 | US20050032727 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 02/10/2005 | US20050032725 useful in the diagnosis, treatment or prevention of conditions characterized by a too-vigorous effector T cell response to antigens |
| 02/10/2005 | US20050032698 includes a divalent cation (zinc chloride) in an amount effective to stabilize the hormone; osteoporosis |
| 02/10/2005 | US20050032696 Muscle transcription factors |
| 02/10/2005 | US20050032693 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 02/10/2005 | US20050032692 Methods of inhibiting tumor cell proliferation |
| 02/10/2005 | US20050032246 By contacting with a sol gel precursor such as diglycerylsilane that is compatible with said membrane-associated molecule such as ion channel proteins, ionophores, G-protein coupled receptors and allowing a gel to form; use in screening for drugs or drug targets, biosensors, microarrays |
| 02/10/2005 | US20050032245 Identifying inhibitors of viral polymerases activity via fluorescence from bound labeled viral polymerase subunits; high throughput assay; viricides; prevention of viral infection |
| 02/10/2005 | US20050032244 Detection using variations in energy levels; hydrophilic, hydrophobic or electrostatics; detector bonded to porous materials and a halophors |
| 02/10/2005 | US20050032243 Using activated charcoal high throughput assay to monitor protein binding interactions; drug biodistribution; drug design |
| 02/10/2005 | US20050032230 Determining concentration of oxygen in a pure gas comprising; separating oxygen, converting to carbon oxide, converting carbon oxide into methane using nickel catalyst, quantifying methane and indirectly extrapolating amount of oxygen in the original gas mixture |
| 02/10/2005 | US20050032228 Method for phosporous quantitation |
| 02/10/2005 | US20050032226 Encoded nanoparticles in paper manufacture |
| 02/10/2005 | US20050032221 Dominant negative variants of methionine aminopeptidase 2 (MetAP2) and clinical uses thereof |
| 02/10/2005 | US20050032201 Method for selectively separating blood cells by using lectin |
| 02/10/2005 | US20050032197 Cell comprising transmembrane kinase for use in identifyiing modulators which effect protein-protein interaction; drug screening |
| 02/10/2005 | US20050032192 Products containing quantum of bioparticles and method for production thereof |
| 02/10/2005 | US20050032190 Beta-secretase substrates and uses thereof |
| 02/10/2005 | US20050032183 Tumor necrosis factor receptor crystal protein for us in treatment and prevention of rheumatic, arthritic, psoriatic, and/or ankylosing spondylitis |
| 02/10/2005 | US20050032172 Expression vector comprising nucleotide sequences coding tumor necrosis factor (FTHMA-) and/or axon guidance receptor (T85) for use in identifying modulators for prevention and/or treatment of cell proliferative or neurological disorders |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032168 17 human secreted proteins |
| 02/10/2005 | US20050032165 Potassium channels, nucleotide sequences encoding them, and methods of using same |
| 02/10/2005 | US20050032158 Using novel g-protein coupled taste receptor (T1R2) as tools in identifying modulators to use as additives which enhance sweetness of foods consumed by animal and humans |
| 02/10/2005 | US20050032149 Enzyme catalyzed isotope labeling |
| 02/10/2005 | US20050032146 Tssk4: a human testis specific serine/threonine kinase |